Lyell Immunopharma (LYEL)
(Delayed Data from NSDQ)
$1.49 USD
-0.01 (-0.67%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $1.29 -0.20 (-13.42%) 7:18 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.20 | -13.12% |
Earnings Summary
For their last quarter, Lyell Immunopharma (LYEL) reported earnings of -$0.24 per share, missing the Zacks Consensus Estimate of -$0.20 per share. This reflects a negative earnings surprise of 20.00%. Look out for LYEL's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.20 per share, reflecting a year-over-year increase of 23.08%.
Earnings History
Price & Consensus
Zacks News for LYEL
Theravance Biopharma (TBPH) Tops Q4 Earnings and Revenue Estimates
LYEL: What are Zacks experts saying now?
Zacks Private Portfolio Services